¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"intergenic suppressor mutation"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
extragenic suppressor mutation
À¯ÀüÀڿܹßÇö¾ïÁ¦µ¹¿¬º¯ÀÌ
suppressor mutation
¾ïÁ¦(µ¹¿¬)º¯ÀÌ
suppressor
¾ïÁ¦ÀÎÀÚ
suppressor area
¾ïÁ¦±¸¿ª
suppressor cell
¾ïÁ¦¼¼Æ÷
suppressor gene
¾ïÁ¦À¯ÀüÀÚ
suppressor T cell
¾ïÁ¦T¼¼Æ÷
allelic mutation
¸Â¼¶µ¹¿¬º¯ÀÌ, ´ë¸³µ¹¿¬º¯ÀÌ
back mutation
¿ªµ¹¿¬º¯ÀÌ, º¹±Íµ¹¿¬º¯ÀÌ
cold-sensitive mutation
Àú¿Â¹Î°¨µ¹¿¬º¯ÀÌ, Àú¿Â°¨¼ö¼ºµ¹¿¬º¯ÀÌ
conditional lethal mutation
Á¶°ÇÄ¡»çµ¹¿¬º¯ÀÌ
conditional mutation
Á¶°Çµ¹¿¬º¯ÀÌ
chromosomal mutation
¿°»öüµ¹¿¬º¯ÀÌ
chromosome mutation
¿°»öüµ¹¿¬º¯ÀÌ
drift mutation
¿¬¼Óº¯ÀÌ
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
7
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
tumor suppressor gene
Á¾¾ç¾ïÁ¦À¯ÀüÀÚ
suppressor
¾ïÁ¦ÀÎÀÚ
mutation
µ¹¿¬º¯ÀÌ
point mutation
Á¡µ¹¿¬º¯ÀÌ
reverse mutation
¿ªµ¹¿¬º¯ÀÌ, º¹±Íµ¹¿¬º¯ÀÌ
somatic mutation
ü¼¼Æ÷µ¹¿¬º¯ÀÌ
mutation rate
µ¹¿¬º¯ÀÌÀ²
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
extragenic suppressor mutation
À¯ÀüÀڿܹßÇö¾ïÁ¦µ¹¿¬º¯ÀÌ
suppressor area
¾ïÁ¦±¸¿ª
crossing-over suppressor
±³Â÷¾ïÁ¦ÀÎÀÚ
suppressor cell
¾ïÁ¦¼¼Æ÷
suppressor T cell
¾ïÁ¦Æ¼¼¼Æ÷
tumor suppressor gene
Á¾¾ç¾ïÁ¦À¯ÀüÀÚ
suppressor
¾ïÁ¦ÀÎÀÚ
soluble immune response suppressor
°¡¿ë¸é¿ª¹ÝÀÀ¾ïÁ¦ÀÎÀÚ
suppressor strip
Á¦Áö¶ì
back mutation
¿ªµ¹¿¬º¯ÀÌ, º¹±Íµ¹¿¬º¯ÀÌ
chromosomal mutation
¿°»öüº¯ÀÌ, ¿°»öüµ¹¿¬º¯ÀÌ
cold-sensitive mutation
Àú¿Â¹Î°¨µ¹¿¬º¯ÀÌ
conditional mutation
Á¶°Çµ¹¿¬º¯ÀÌ
conditional lethal mutation
Á¶°ÇÄ¡»çµ¹¿¬º¯ÀÌ
dominant mutation
¿ì¼ºµ¹¿¬º¯ÀÌ
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
14
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
anti-idiotypic T suppressor cell
Ç×°³º°Æ¯ÀÌÇü ¾ïÁ¦T¼¼Æ÷
gene, suppressor
¹ßÇö¾ïÁ¦À¯ÀüÀÚ
frameshift mutation
ÇØµ¶Æ² µ¹¿¬º¯ÀÌ, ÇÁ·¹ÀÓ½¬ÇÁÆ® µ¹¿¬º¯ÀÌ
genetic mutation
À¯ÀüÀû µ¹¿¬º¯ÀÌ
genomic mutation
À¯ÀüÀÚµ¹¿¬º¯ÀÌ
induced mutation
À¯¹ßµ¹¿¬º¯ÀÌ
induced mutation
À¯¹ß¼º µ¹¿¬º¯ÀÌ.
plaque morphology mutation
ÇöóÅ© ÇüÅ µ¹¿¬º¯ÀÌ
plaque-type mutation
ÇöóÅ©Çü µ¹¿¬º¯ÀÌ
point mutation
Á¡ µ¹¿¬º¯ÀÌ
point mutation
Á¡µ¹¿¬º¯ÀÌ
population mutation
Áý´Ü±ºµ¹¿¬º¯ÀÌ(¡ÔÍæÔܨì¶).
recessive mutation
¿¼ºµ¹¿¬º¯ÀÌ(æëàõÔÍæÔܨì¶).
recessive mutation
¿¼ºµ¹¿¬º¯ÀÌ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
mutation, extragenic suppressor
À¯ÀüÀÚ¿Ü ¹ßÇö¾ïÁ¦µ¹¿¬º¯ÀÌ
mutation, suppressor
¾ïÁ¦ µ¹¿¬º¯ÀÌ (¹ßÇö)
suppressor mutation
¾ï¾Ð(ÀÚ)º¯ÀÌ.
anti-idiotypic T suppressor cell
Ç×°³º°Æ¯ÀÌÇü ¾ïÁ¦T¼¼Æ÷
cancer suppressor genes
¾Ï¾ïÁ¦À¯ÀüÀÚ(äßåäð¤ë¶îîí)
cell, suppressor T
¾ïÁ¦T¼¼Æ÷
crossing over suppressor
±³Â÷¾ï¾ÐÀÎÀÚ(¡åääâì×í).
cytotoxic/suppressor T cell
¼¼Æ÷µ¶¼º/¾ïÁ¦ T ¼¼Æ÷
gene, suppressor
¹ßÇö¾ïÁ¦À¯ÀüÀÚ
soluble immune response suppressor
°¡¿ë¼º ¸é¿ª¹ÝÀÀ¾ïÁ¦ÀÎÀÚ
suppressor
¾ï¾ÐÀÚ, ¾ï¾ÏÀ¯ÀüÀÚ.
suppressor T cell
¾ïÁ¦ T ¼¼Æ÷
suppressor T cell
¾ïÁ¦T¼¼Æ÷, Á¦¾îT¼¼Æ÷.
suppressor Tcell
¾ïÁ¦ T ¼¼Æ÷
suppressor area
¾ïÁ¦¿µ¿ª.
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½